GO:0004901 granulocyte macrophage colony-stimulating factor receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004901 describes the molecular function of binding granulocyte macrophage colony-stimulating factor (GM-CSF) and transmitting that signal across the membrane to initiate a change in cell activity.
• The receptor is a heterodimer built from a ligand-specific alpha chain (CSF2RA) and a shared beta chain (CSF2RB) that is also used by IL-3 and IL-5 receptors.
• GM-CSF receptor signaling drives survival, proliferation, differentiation and activation of myeloid cells such as neutrophils, monocytes, macrophages and dendritic cells.
• Dysregulated GM-CSF receptor activity is linked to inflammatory and autoimmune conditions, eosinophilic esophagitis, pain sensitization and myeloid malignancies.
• The receptor is a validated target for recombinant fusion toxins and structure-based mimetics, making it a tractable experimental handle.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal dissection of CSF2RA and CSF2RB function in immune and disease contexts.
Description
Granulocyte macrophage colony-stimulating factor receptor activity (GO:0004901) is the molecular function by which a cell binds GM-CSF and converts that binding event into an intracellular signal that changes cell behavior. This activity sits at the top of a cytokine signaling cascade that is central to myeloid cell biology, controlling the survival, proliferation and functional activation of neutrophils, monocytes, macrophages and dendritic cells. Because the receptor is expressed on a wide range of hematopoietic and non-hematopoietic cells, its activity influences not only steady-state hematopoiesis but also inflammation, tissue remodeling and host defense. At the molecular level, the GM-CSF receptor is a heterodimer composed of a ligand-specific alpha subunit (CSF2RA) and a shared beta subunit (CSF2RB) that is also used by the IL-3 and IL-5 receptors. Ligand binding to CSF2RA recruits CSF2RB, which lacks intrinsic kinase activity and therefore signals by recruiting cytoplasmic tyrosine kinases and adaptor proteins. This architecture explains why GM-CSF, IL-3 and IL-5 share overlapping but non-identical downstream outputs. For researchers, GO:0004901 is a useful annotation because it captures a single, experimentally testable function: does a cell bind GM-CSF and transduce a signal? Assays that measure receptor occupancy, phosphorylation of downstream effectors, or GM-CSF-dependent proliferation and differentiation all report on this activity. The term is therefore relevant to immunology, hematology, inflammation research and oncology, and it is a natural entry point for CRISPR-based functional genomics of cytokine signaling.
granulocyte macrophage colony-stimulating factor receptor activity At A Glance
| GO ID | GO:0004901 |
|---|---|
| GO term | granulocyte macrophage colony-stimulating factor receptor activity |
| Ontology | molecular_function |
| Synonym | CSF2R; CSF-2 receptor activity; GM-CSF receptor activity; GMC-SF receptor activity; granulocyte macrophage colony stimulating factor receptor activity |
| Major function | Binds GM-CSF and transmits the signal across the membrane to initiate a change in cell activity |
| Ligand | Granulocyte macrophage colony-stimulating factor (GM-CSF) |
| Receptor subunits | CSF2RA (ligand-specific alpha chain) and CSF2RB (shared beta chain) |
| Shared beta chain partners | IL-3 receptor and IL-5 receptor also use CSF2RB |
| Downstream signaling | Recruitment of cytoplasmic tyrosine kinases and adaptor proteins leading to phosphorylation cascades |
| Cell types | Neutrophils, monocytes, macrophages, dendritic cells and other myeloid cells |
What Is GO:0004901?
GO:0004901, granulocyte macrophage colony-stimulating factor receptor activity, is defined as combining with granulocyte macrophage colony-stimulating factor (GM-CSF) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. In practice, this means the receptor must both bind GM-CSF with sufficient affinity and couple that binding to intracellular signaling events that alter the target cell's behavior.
Why Is granulocyte macrophage colony-stimulating factor receptor activity Important in Cell Biology?
GM-CSF receptor activity is important because it is a master regulator of myeloid cell survival, proliferation and activation, and because its dysregulation contributes to a broad spectrum of human diseases ranging from inflammatory and autoimmune conditions to myeloid malignancies. The receptor is also a clinically validated target: recombinant fusion toxins directed to the GM-CSF receptor have been developed to selectively eliminate receptor-bearing cells, and structure-based mimetics of GM-CSF have been designed to modulate receptor function. Understanding GO:0004901 therefore has direct implications for immunology, hematology, inflammation research and drug development.
• Controls survival, proliferation and differentiation of neutrophils, monocytes, macrophages and dendritic cells.
• Shapes adaptive immunity by influencing antigen-presenting cell function and T cell priming.
• Contributes to wound healing and tissue remodeling through myeloid cell recruitment and activation.
• Is implicated in eosinophilic esophagitis and epithelial/vascular remodeling.
• Has been linked to nociceptor activation and pain sensitization.
• Provides a target for recombinant fusion toxins that selectively kill receptor-expressing cells.
• Is a template for structure-based design of GM-CSF mimetics and receptor modulators.
• Serves as a model system for understanding shared beta-chain cytokine receptor signaling.
• Is a tractable entry point for CRISPR functional genomics of cytokine signaling.
• Informs development of immunotherapies and anti-inflammatory strategies.
What Happens During granulocyte macrophage colony-stimulating factor receptor activity?
Ligand binding and receptor assembly
In simple terms: GM-CSF docks onto the alpha chain of the receptor, which then recruits the beta chain to form an active signaling complex.
The GM-CSF receptor is a heterodimer. The ligand-specific alpha chain, CSF2RA, binds GM-CSF with low affinity; ligand binding then recruits the shared beta chain, CSF2RB, to form a high-affinity signaling complex. CSF2RB is also used by the IL-3 and IL-5 receptors, which explains why these cytokines share overlapping biological activities. Receptor assembly is the first committed step of GO:0004901 and is required for all downstream signaling.
Transmembrane signal transmission
In simple terms: The receptor spans the membrane and, once assembled, changes shape to pass the signal from the outside to the inside of the cell.
The QuickGO definition of GO:0004901 explicitly requires transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. Because CSF2RB lacks intrinsic kinase activity, signal transmission depends on conformational changes in the receptor complex that create docking sites for cytoplasmic signaling molecules. This step converts the extracellular ligand-binding event into an intracellular biochemical signal.
Activation of cytoplasmic tyrosine kinases and adaptors
In simple terms: Once the receptor is assembled, it recruits enzymes inside the cell that add phosphate tags to proteins, turning on the signal.
The assembled GM-CSF receptor recruits cytoplasmic tyrosine kinases and adaptor proteins that initiate phosphorylation cascades. These events propagate the signal to downstream pathways that control gene expression, metabolism and cell fate. The specific kinases and adaptors recruited are shared in part with the IL-3 and IL-5 receptors because of the common CSF2RB subunit.
Downstream cellular responses
In simple terms: The signal ultimately tells the cell to survive, grow, differentiate or become activated.
GM-CSF receptor activity drives survival, proliferation, differentiation and functional activation of myeloid cells including neutrophils, monocytes, macrophages and dendritic cells. In dendritic cells, GM-CSF receptor signaling supports the development and function of subsets that prime CD8+ T cells. In neutrophils, receptor engagement is associated with activation responses. These cellular outputs are the physiological readout of GO:0004901.
Regulation and termination of signaling
In simple terms: The cell has brakes that shut the signal off so that it does not run out of control.
Like other cytokine receptors, GM-CSF receptor signaling is subject to negative regulation that prevents excessive or prolonged activation. The precise molecular brakes are context-dependent, but the principle that receptor activity is tightly controlled is well established for this receptor family. Loss of such control can contribute to inflammatory or malignant phenotypes.
Key Genes Involved in GO:0004901 granulocyte macrophage colony-stimulating factor receptor activity
The following genes and proteins are the principal molecular players in granulocyte macrophage colony-stimulating factor receptor activity (GO:0004901) and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CSF2 | Encodes GM-CSF, the ligand that binds and activates the receptor | Ligand-side control of receptor activity; target for modulation in inflammation and immunity |
| CSF2RA | Ligand-specific alpha chain of the GM-CSF receptor; binds GM-CSF | Determines ligand specificity; knockout and point-mutation studies define binding determinants |
| CSF2RB | Shared beta chain; recruited after ligand binding; essential for signaling | Common subunit for GM-CSF, IL-3 and IL-5 receptors; central to signal transduction |
| JAK2 | Cytoplasmic tyrosine kinase recruited to the receptor complex | Phosphorylates downstream substrates; key node for signaling assays |
| STAT5A | Transcription factor activated downstream of receptor signaling | Readout of receptor activity; target for functional genomics |
| STAT5B | Transcription factor activated downstream of receptor signaling | Readout of receptor activity; target for functional genomics |
| STAT3 | Transcription factor implicated in cytokine receptor signaling | Contributes to gene expression changes downstream of receptor activation |
| PIK3CD | Phosphoinositide 3-kinase catalytic subunit implicated in cytokine signaling | Links receptor activity to survival and metabolic pathways |
| MAPK1 | Mitogen-activated protein kinase downstream of cytokine receptors | Propagates proliferative signals from the receptor |
| MAPK3 | Mitogen-activated protein kinase downstream of cytokine receptors | Propagates proliferative signals from the receptor |
| CD1C | Marker of a human dendritic cell subset responsive to GM-CSF | Used to identify GM-CSF-responsive dendritic cells in functional studies |
| CD163 | Marker of a dendritic cell subset with GM-CSF-related function | Helps define GM-CSF-responsive antigen-presenting cell populations |
| ITGAE | Encodes CD103; marks T cells primed by GM-CSF-influenced dendritic cells | Links receptor activity to adaptive immune priming |
| CD8A | Marks cytotoxic T cells whose priming is influenced by GM-CSF-responsive dendritic cells | Readout of downstream immune effects of receptor activity |
| TRPV1 | Nociceptor ion channel implicated in GM-CSF-mediated pain sensitization | Connects receptor activity to sensory neuron activation |
| IL5 | Cytokine sharing the CSF2RB beta chain | Explains overlapping biology with GM-CSF receptor signaling |
| IL3 | Cytokine sharing the CSF2RB beta chain | Explains overlapping biology with GM-CSF receptor signaling |
| CSF3R | Receptor for G-CSF, a related myeloid cytokine receptor | Provides comparative context for myeloid cytokine receptor biology |
How Is granulocyte macrophage colony-stimulating factor receptor activity Regulated?
GM-CSF receptor activity is regulated at multiple levels. Ligand availability controls the initial binding event, and receptor assembly with the shared beta chain is required for high-affinity signaling. Because CSF2RB lacks intrinsic kinase activity, signal propagation depends on recruitment of cytoplasmic tyrosine kinases and adaptor proteins, and these interactions are subject to negative feedback that terminates signaling. In disease contexts, persistent or excessive receptor activity has been associated with inflammatory remodeling and pain sensitization, indicating that regulatory checkpoints can be overwhelmed or bypassed. The precise molecular regulators are context-dependent, and researchers should validate them experimentally in their model system.
granulocyte macrophage colony-stimulating factor receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CSF2 | Inflammatory and allergic disease; wound healing | Knockout or overexpression in myeloid cell lines and primary immune cells |
| CSF2RA | GM-CSF receptor function; fusion toxin targeting | Point-mutation and knockout models to map ligand-binding determinants |
| CSF2RB | Shared beta-chain signaling; inflammatory remodeling | Knockout models to separate GM-CSF from IL-3/IL-5 signaling |
| TRPV1 | Nociceptor activation and pain | Co-culture and sensory neuron models with receptor modulation |
| CD1C | Dendritic cell subsets and T cell priming | Knock-in reporter models to track GM-CSF-responsive dendritic cells |
Inflammatory and allergic disease
GM-CSF receptor activity is implicated in inflammatory and allergic conditions. In experimental eosinophilic esophagitis, targeting GM-CSF reduced epithelial and vascular remodeling, indicating that receptor-driven signaling contributes to tissue pathology. These findings support the receptor as a candidate target for anti-inflammatory strategies in allergic disease.
Pain and nociceptor activation
GM-CSF has been described as an indirect mediator of nociceptor activation and pain. Experimental evidence indicates that GM-CSF signaling can sensitize sensory neurons, linking receptor activity to pain pathways. This expands the relevance of GO:0004901 beyond classical immunology into neuroimmune interactions.
Myeloid malignancy and therapeutic targeting
Because the GM-CSF receptor is expressed on myeloid cells, it has been exploited as a target for recombinant fusion toxins designed to selectively eliminate receptor-bearing cells. This approach illustrates how receptor activity can be used to direct therapeutic payloads and provides a rationale for studying receptor expression and function in myeloid malignancies.
Adaptive immunity and immunotherapy
GM-CSF receptor activity influences dendritic cell subsets that prime CD8+ T cells, connecting the receptor to adaptive immune responses. GM-CSF also exerts direct effects on adaptive immunogenesis, which has implications for vaccine design and immunotherapy. These roles make the receptor a relevant node in immuno-oncology and vaccine research.
From granulocyte macrophage colony-stimulating factor receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CSF2RA abolish GM-CSF-dependent signaling? | CSF2RA knockout cell line or primary cells |
| Which residues in CSF2RA mediate ligand binding? | Point-mutation knock-in of candidate residues |
| Can a tagged receptor be used to track trafficking? | Tagged knock-in of CSF2RA or CSF2RB |
| Does overexpression of CSF2RB enhance signaling? | Overexpression model in a myeloid cell line |
| Which genes are required for GM-CSF-dependent dendritic cell function? | CRISPR library screening in dendritic cell models |
| Does receptor activity drive inflammatory remodeling in vivo? | Knockout or conditional knockout mouse models |
How to Study the granulocyte macrophage colony-stimulating factor receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ligand-binding assay | Direct binding of GM-CSF to receptor | Confirm receptor expression and affinity |
| Phospho-signaling assay | Activation of downstream kinases and STATs | Measure signal transmission after receptor engagement |
| Proliferation assay | GM-CSF-dependent cell growth | Functional readout of receptor activity |
| Dendritic cell priming assay | CD8+ T cell priming by dendritic cells | Link receptor activity to adaptive immunity |
| RNA sequencing | Transcriptional changes downstream of receptor activation | Define the receptor-regulated gene network |
| Proteomics | Protein abundance and modification changes | Identify signaling effectors and biomarkers |
| Fusion toxin cytotoxicity assay | Selective killing of receptor-expressing cells | Validate receptor as a therapeutic target |
Ligand-binding and receptor activation assays
Receptor activity can be measured by ligand-binding assays, receptor phosphorylation, and downstream phosphorylation of signaling intermediates. These assays directly report on the binding and signal-transmission steps that define GO:0004901. They are typically performed in myeloid cell lines or primary cells that express the receptor.
Functional cellular readouts
GM-CSF-dependent survival, proliferation, differentiation and activation are functional readouts of receptor activity. Dendritic cell assays that measure priming of CD8+ T cells can connect receptor activity to adaptive immune outcomes. Neutrophil activation assays provide a complementary myeloid readout.
Transcriptomic and proteomic profiling
RNA sequencing and proteomics can identify gene expression and protein changes downstream of receptor activation. These approaches help define the regulatory network controlled by GO:0004901 in a given cell type. They are particularly useful when comparing knockout, point-mutant and overexpressing models.
Targeted toxin and mimetic approaches
Recombinant fusion toxins targeted to the GM-CSF receptor can be used to selectively eliminate receptor-expressing cells, providing a functional test of receptor presence and activity. Structure-based mimetics of GM-CSF can be used to probe receptor activation requirements. These tools complement genetic approaches.
How CRISPR Can Be Used to Study GO:0004901 granulocyte macrophage colony-stimulating factor receptor activity
Knockout
CRISPR knockout of CSF2RA or CSF2RB is the most direct way to test whether a cellular response depends on GM-CSF receptor activity. Knockout models can be used to separate GM-CSF-specific effects from those mediated by IL-3 or IL-5, which share CSF2RB. They are also useful for validating downstream signaling nodes identified in screens.
Point Mutation
Point-mutation knock-in can be used to map residues in CSF2RA or CSF2RB that are required for ligand binding or signal transmission. Such models allow fine-grained structure-function analysis without eliminating the protein entirely. They are particularly valuable when a complete knockout is lethal or confounds interpretation.
Knock-in
Tagged knock-in of CSF2RA or CSF2RB enables tracking of receptor localization, trafficking and interaction partners in live cells. Reporter knock-in can also be used to monitor receptor promoter activity in specific cell types. These models complement functional assays by providing spatial and temporal information.
Overexpression
Overexpression of CSF2 or CSF2RA/CSF2RB can be used to amplify receptor signaling and test gain-of-function hypotheses. Overexpression models are useful for identifying downstream pathways that become saturated or rewired under high receptor activity. They can also be used to test whether receptor activity is sufficient to drive a given cellular phenotype.
How EDITGENE Supports granulocyte macrophage colony-stimulating factor receptor activity Research
Researchers studying granulocyte macrophage colony-stimulating factor receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, myeloid cell function or disease phenotypes. EDITGENE provides the CRISPR tools and services needed to build and validate such models, from single-gene knockouts to genome-wide screens.
Contact EDITGENE today to design your custom CRISPR model for granulocyte macrophage colony-stimulating factor receptor activity research.
Frequently Asked Questions About granulocyte macrophage colony-stimulating factor receptor activity
What is granulocyte macrophage colony-stimulating factor receptor activity?
It is the molecular function defined by GO:0004901, in which a cell binds GM-CSF and transmits the signal across the membrane to initiate a change in cell activity.
What genes are involved in granulocyte macrophage colony-stimulating factor receptor activity?
The core genes are CSF2 (the ligand), CSF2RA (the ligand-specific alpha chain) and CSF2RB (the shared beta chain), with downstream signaling through kinases and STAT proteins.
What is the GO ID for GM-CSF receptor activity?
The GO ID is GO:0004901.
Which receptor subunits form the GM-CSF receptor?
The receptor is a heterodimer of CSF2RA and CSF2RB, where CSF2RB is shared with the IL-3 and IL-5 receptors.
What diseases are linked to GM-CSF receptor activity?
It has been linked to inflammatory and allergic disease, eosinophilic esophagitis, pain sensitization and myeloid malignancies.
How is GM-CSF receptor activity measured in the lab?
Common methods include ligand-binding assays, phospho-signaling assays, proliferation assays and dendritic cell functional assays.
Can CRISPR be used to study GM-CSF receptor activity?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models are all used to dissect receptor function and downstream signaling.
What is the role of CSF2RB in GM-CSF signaling?
CSF2RB is the shared beta chain that is recruited after ligand binding and is essential for signal transmission because it provides docking sites for cytoplasmic kinases and adaptors.
Is the GM-CSF receptor a therapeutic target?
Yes, it has been targeted with recombinant fusion toxins and is a template for structure-based mimetics.
What cell types express the GM-CSF receptor?
It is expressed on myeloid cells including neutrophils, monocytes, macrophages and dendritic cells, and its activity influences their survival, proliferation and activation.
Conclusion
Granulocyte macrophage colony-stimulating factor receptor activity (GO:0004901) is a central molecular function in myeloid cell biology, linking GM-CSF binding to survival, proliferation, differentiation and activation programs. Its dysregulation contributes to inflammatory, allergic, painful and malignant conditions, and the receptor is a validated target for fusion toxins and mimetics. CRISPR-based knockout, point-mutation, knock-in and overexpression models provide the causal tools needed to dissect this activity in health and disease.
References
- 1. Ead JK et al.. 2023. Granulocyte-macrophage colony-stimulating factor: Conductor of the wound healing orchestra?. Int Wound J 20(4):1229-1234 PMID: 36632762
- 2. Rapoport AP et al.. 1992. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation.. Blood Rev 6(1):43-57 PMID: 1375123
- 3. Bourdely P et al.. 2020. Transcriptional and Functional Analysis of CD1c(+) Human Dendritic Cells Identifies a CD163(+) Subset Priming CD8(+)CD103(+) T Cells.. Immunity 53(2):335-352.e8 PMID: 32610077
- 4. Bendel AE et al.. 1997. A recombinant fusion toxin targeted to the granulocyte-macrophage colony-stimulating factor receptor.. Leuk Lymphoma 25(3-4):257-70 PMID: 9168436
- 5. Tewari D et al.. 2020. Granulocyte-Macrophage Colony Stimulating Factor As an Indirect Mediator of Nociceptor Activation and Pain.. J Neurosci 40(11):2189-2199 PMID: 32019828
- 6. Seledtsov VI et al.. 2019. Directs effects of granulocyte-macrophage colony stimulating factor (GM-CSF) on adaptive immunogenesis.. Hum Vaccin Immunother 15(12):2903-2909 PMID: 31063025
- 7. McNamee EN et al.. 2017. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.. Allergy 72(8):1232-1242 PMID: 27926989
- 8. Monfardini C et al.. 2002. Structure-based design of mimetics for granulocyte-macrophage colony stimulating factor (GM-CSF).. Curr Pharm Des 8(24):2185-99 PMID: 12369862
